The Cigna Group vs Unum Group, two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Cigna runs its $75B enterprise on 0.04 turns of debt, close to none for an insurer its size; Unum carries a moderate 0.35 running disability and group life. Neither balance sheet decides anything, so the economics do: Unum keeps 5.9% of premium revenue as profit against Cigna's 2.3%, but Cigna's pharmacy-benefits machine converts scale into an 11.8% free-cash figure (float-flattered, as insurance cash always is) against Unum's 3.6%. The multiples price Unum dearer, 19.5 times earnings against 12, which reads backwards until the mix is considered: Cigna's earnings lean on a PBM business Washington keeps circling, Unum's on actuarial tables that rarely make headlines. Both pay near-2% dividends. The premium is for boredom; the discount is for policy risk.
Comparison updated 2026-07-10.
| Metric | CI | UNM |
|---|---|---|
| Price | $282.39 | $90.06 |
| Market cap | $74.6B | $14.8B |
| Sector | Managed Care | Managed Care |
| Stage | Mature | Mature |
| P/E | 12.0 | 19.5 |
| P/B | 1.76 | 1.36 |
| P/S | 0.27 | 1.11 |
| EV/EBITDA | 5.6 | — |
| Revenue growth | +8.9% | +4.4% |
| Operating margin | 3.4% | — |
| Net margin | 2.3% | 5.9% |
| Return on equity | 14.8% | 7.2% |
| Return on assets | 4.1% | 1.3% |
| Return on invested capital | 17.9% | — |
| FCF yield | 11.8% | 3.6% |
| Dividend yield | 2.1% | 1.9% |
| Debt / equity | 0.04 | 0.35 |
| Current ratio | 0.82 | — |
| Altman Z (solvency) | 2.64 | 0.69 |
| Piotroski F (quality) | 6 / 9 | 9 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.